ASX non-bank lenders: Future of Aussie finance?
Non-bank lenders surge in Australia’s credit market, filling gaps left by traditional banks.
Stockhead
Don’t let tech run stop you looking beyond Wall Street
Wall Street’s Magnificent Seven have dominated global gains. But Franklin Templeton suggests gains could be found elsewhere going forward.
Here’s why vanadium is heating up
Vanadium is the other battery metal and demand could increase as VRFBs hit the mainstream.
Rise and Shine: Everything you need to know before the ASX opens
Good morning, and Happy Thursday! Here’s everything you need to know before the ASX opens today.
AI to lead copper’s North American revival
North American copper demand has been stagnant for years. AI could turn it back into a literal powerhouse.
Sticky CPI pulls pants off ASX as August rate hike looms
Not a great day for local markets or mortgage holders. The May CPI read shows inflation remains heated if not hot and markets fell sharply on the news.
ASX Small Caps Lunch Wrap: 26 June, 2024
Local markets have been dealt a blow by a shock +0.4% jump in inflation in May.
The sun is shining today in Mexico for goldie Mithril
Five ASX resources stocks moved the needle up in early trade today across gold, graphite and even potash.
Cleo on track for FDA approval of ovarian test
ASX health stock Cleo Diagnostics now has a clearer path to US approval for its blood test to detect ovarian cancer, thanks to FDA advice.
Cap raises and consultants drive a quiet morning on the ASX
Good morning, and welcome to Stockhead’s Top 10 at 11, a short, sharp update to help frame the trading day.
Nvidia rebounds; EV maker Rivian up 53pc
Nvidia rebounds with a +6.75pc surge after recent declines, while Novo Nordisk doubles down on Wegovy and Ozempic.
Nvidia: The chips are down and everyone’s buying it
Nvidia stands corrected, but it’s the strength of the competition – chipmakers like Micron are finding their footing and broker support.
FDA joy here or near for these ASX biotechs
FDA approval can be a superpower for an ASX biotech, opening doors to big profits. These stocks have gained it this year, or are close.
Aussie home sales hit 15-year profit highs
The profitability of flogging your Aussie home has hit an almost 15-year high, according to CoreLogic data.
Morgans’ ASX tech picks earning, not burning cash
Stockbroker Morgans says these three ASX tech stocks stand out for being cash earners rather than burners with funds for future growth.
Rise and Shine: Everything you need to know before the ASX opens
Good morning, and Happy Wednesday! Here’s everything you need to know before the ASX opens today.
Investors sink Paladin stock on Canada deal
Investors have sold off uranium miner Paladin on a $1bn-plus Canadian acquisition.
The ASX surged on Tuesday, with all sectors in the green
The local benchmark had its best day in almost two months after a mixed lead overnight on Wall Street.
Helix extends its Cobar copper-gold hunt
Helix Resources is a standout ressie gainer today on copper-gold news. MTM has also made a pretty flash reveal.
ASX Small Caps Lunch Wrap: Who’s been busted playing dress-ups in the US this week?
After a rough start to the week local markets opened higher on Tuesday with every sector enjoying some time in the sunshine, despite a lull among tech stocks led by market volatility in that sector.
Original URL: https://www.news.com.au/finance/business/stockhead/page/101